17-Dec-2024    Exosomes go to war: INOVIQ's breast cancer therapy  
 
13-Dec-2024    INOVIQ (ASX:IIQ) - Webinar Presentation  
 
11-Dec-2024    Breakthrough results for INOVIQ's ovarian cancer test  
 
6-Dec-2024    Hot Stocks: Northern Star Resources, Hazer Group, INOVIQ  
 
5-Dec-2024    INOVIQ completes study for breast cancer test  
 
3-Dec-2024    94% accuracy: INOVIQ's game-changing ovarian cancer test  
 
31-Oct-2024    Cancer detection and exosome breakthroughs drive INOVIQ's Q1  
 
20-Aug-2024    A "fingerprint" for the early detection of Parkinson's? IIQ builds on previous Alzheimer's validation  
 
8-Aug-2024    Stockhead Investor Guide: Health & Biotech FY2025 featuring Tim Boreham  

INOVIQ is featured on page 18

 		 
12-Jun-2024    Stocks of the Hour: Reach Resources, Nico Resources, Global Lithium Resources, INOVIQ  
 
7-Jun-2024    Ahhhh … wellness company delivers nerve-calming goods  
 
3-Jun-2024    Stocks of the Hour: Immutep, INOVIQ, Eastern Metals  
 
12-Apr-2024    INOVIQ (ASX:IIQ) - Webinar Presentation  
 
21-Feb-2024    Fundie Merchant Group picks four biotech stocks that could rip as sector hits rude health again  
 
13-Oct-2023    David Williams to join INOVIQ board  
 
25-Sep-2023    ASX Small and Mid-Cap Conference September 2023 | INOVIQ Ltd (ASX: IIQ)  
 
5-Sep-2023    Stocks of the Hour: Empire Energy, INOVIQ, Southern Cross Gold  
 
26-Jul-2023    INOVIQ strives to lift the bar on breast and ovarian cancer diagnostics  
 
10-Jul-2023    INOVIQ's breast cancer test outperforms leading approved test  
 
7-Jul-2023    The Market Herald: INOVIQ (ASX:IIQ) teams up with Promega in global marketing agreement  
 
6-Jul-2023    Ausbiz: Opportunities in small cap | INOVIQ - Promega collaboration  
 
6-Jul-2023    Stockhead: Key deal signed by INOVIQ  
 
2-Jul-2023    Channel 7’s Flashpoint featured INOVIQ in its ASX - Runners of the Week  
 
27-Jun-2023    Breakthrough breast cancer test delivers hope in clinical study  
 
27-Jun-2023    ASX Health stocks: INOVIQ soars 44pc on clinical data for breast cancer test  
 
27-Jun-2023    Stocks of the Hour: INOVIQ, Forrestania, Lincoln, Tamboran  
 
13-Apr-2023    INOVIQ CSO Professor Greg Rice receives placentology scientific award  
 
8-Feb-2023    Sectors mixed as ASX edges 0.35% higher  
 
8-Feb-2023    Stocks of the Hour: Tennant Minerals, Latin Resources, INOVIQ  
 
21-Dec-2022    Passing of Professor Allan Cripps AO  
 
15-Dec-2022    INOVIQ presents at the MST Access Diagnostics Forum  
 
13-Dec-2022    Stocks of the Hour: Kingwest Resources, Doctor Care Anywhere, INOVIQ  
 
28-Nov-2022    China's lockdown rampage causes lower start to ASX  
 
25-Nov-2022    Lithium stocks falling, Critical Minerals Summit commencing: ASX up 0.29% at noon  
 
16-Nov-2022    The Australian: Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US  
 
13-Oct-2022    The Market Herald: INOVIQ signs agreement with Nicoya Lifesciences to develop SubB2M-based test  
 
13-Oct-2022    Financials keeping the local market in the green: ASX up 0.51% at noon  
 
27-Sep-2022    Stockhead Health & Biotech Investment Guide  
 
8-Sep-2022    INOVIQ carving itself healthy share of multi-billion dollar medical diagnostics market  
 
29-Jul-2022    INOVIQ (ASX:IIQ) discusses US milestones  
 
26-Jul-2022    INOVIQ study validates the use of SubB2M as an aid in diagnosing malignant melanoma  
 
26-Jul-2022    Energy, miners and BNPL shares lead the way: Aus shares close 0.3% higher  
 
26-Jul-2022    ASX in a holding pattern: Aus shares 0.2% higher at noon  
 
22-Jul-2022    INOVIQ expands US footprint with new sales team  
 
1-Jul-2022    Energy and miners drag ASX lower, down 0.6% over the week  
 
1-Jul-2022    INOVIQ (ASX:IIQ) granted SubB2M US patent for diagnostic applications  
 
22-Apr-2022    Inoviq expands collaboration with UQ to develop exosome-based ovarian cancer screening test  
 
5-Apr-2022    INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions  
 
21-Dec-2021    Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests  
 
4-Nov-2021    BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021  
 
15-Feb-2021    INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.  
 
14-Feb-2021    INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.  
 
3-Dec-2020    Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.  
 
3-Sep-2020    AusBiotech: Government announces support for COVID-19 research projects  
 
10-Aug-2020    INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests  
 
24-Apr-2020    INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.  
 
23-Oct-2018    Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer  
 
23-Oct-2018    Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection  
 
21-May-2018    Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies  
 
21-May-2018    Article published by finfeed INOVIQ inks critical deal to develop autoantibody test  
 
18-May-2018    Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation  
 
18-May-2018    Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay  
 
10-Jan-2018    INOVIQ announces positive results from ovarian cancer test  
 
9-Jan-2018    Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study  
 
2-Jan-2017    Interview of INOVIQ LSL Executive Director and CSO Dr Irmgard Irminger-Finger by Startwerk “BARD1AG SA: The real fight against lung cancer”